期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Plants: The Future Pharmaceutical Factory
1
作者 Bipradut Sil sumita jha 《American Journal of Plant Sciences》 2014年第3期319-327,共9页
The main objective of this study was to identify prospects, advantages and challenges of plant molecular farming. Plant-made pharmaceuticals (PMPs) and plant made vaccines (PMVs) were intended to be used for human con... The main objective of this study was to identify prospects, advantages and challenges of plant molecular farming. Plant-made pharmaceuticals (PMPs) and plant made vaccines (PMVs) were intended to be used for human consumption. A broad range of plants, including crops, vegetables and fruits have been investigated for their applicability in production of pharmaceuticals over the last two decades. At present, mainly maize, rice, tobacco and safflower are used in open field production. Contained bioreactor-type systems focus on moss, algae and plant organ culture. Expression systems include stable transformation of plant genomes—both nuclear and plastid, which are also used in the generation of genetically modified crops, plant-viruses and transient expressions. Each expression system (production platform) offers different advantages and disadvantages. Production platform choice is perceptive and depends on a broad range of criterion. This study is based on literature reviews, document analysis and internet database browsing. 展开更多
关键词 PMPs PRODUCTION PLATFORM Pharmaceuticals TRANSFORMATION GENE EXPRESSION
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部